Association of a 31bp VNTR in the CBS gene with postload homocysteine concentrations in the Framingham Offspring Study

European Journal of Human Genetics

Volumn 14, Issue 10, 2006, Pages 1125-1129

  Lievers, Karin J A ^a   Kluijtmans, Leo A J ^a   Blom, Henk J ^a   Wilson, Peter W ^b   Selhub, Jacob ^c   Ordovas, Jose M ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

Cystathionine synthase (CBS); Framingham; Homocysteine; Hyperhomocysteinemia; VNTR

Indexed keywords

CREATININE; CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; GENOMIC DNA; HOMOCYSTEINE; MESSENGER RNA; METHIONINE; PYRIDOXINE; DIAGNOSTIC AGENT;

ADULT; AGE; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; INTRON; LOADING TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; RNA SPLICING; SEX DIFFERENCE; VARIABLE NUMBER OF TANDEM REPEAT; VITAMIN BLOOD LEVEL; BLOOD; COHORT ANALYSIS; GENETICS; MIDDLE AGED; NUCLEAR FAMILY;

AGED; COHORT STUDIES; CYSTATHIONINE BETA-SYNTHASE; FEMALE; FOLIC ACID; HETEROZYGOTE; HOMOCYSTEINE; HUMANS; MALE; METHIONINE; MIDDLE AGED; MINISATELLITE REPEATS; NUCLEAR FAMILY; VITAMIN B 12; VITAMIN B 6;

EID: 33749047853     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201677     Document Type: Article

References (20)

1. Refsum H, Ueland PM, Nygard O, Vollset SE: Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49: 31-62.
2. Ueland PM, Refsum H, Beresford SA, Vollset SE: The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000; 72: 324-332.
3. Bostom AG, Jacques PF, Nadeau MR, Williams RR, Ellison RC, Selhub J: Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: Initial results from the NHLBI Family Heart Study. Atherosclerosis 1995; 116: 147-151.
4. Kang SS, Wong PW: Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia. Atherosclerosis 1996; 119: 135-138.
5. Verhoef P, Kok FJ, Kruyssen DA et al: Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 989-995.
6. Mudd SH, Levy HL, Skovby F: Disorders of transsulfuration. In: Scriver CS, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and molecular basis of inherited disease, 7 edn. New York: McGraw-Hill, 1995, pp 1279-1327.
7. Lievers KJ, Kluijtmans LA, Heil SG et al: A 31 bp VNTR in the cystathionine beta-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels. Eur J Hum Genet 2001; 9: 583-589.
8. Yang F, Hanson NQ, Schwichtenberg K, Tsai MY: Variable number tandem repeat in exon/intron border of the cystathionine beta-synthase gene: A single nucleotide substitution in the second repeat prevents multiple alternate splicing. Am J Med Genet 2000; 95: 385-390.
9. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP: The Framingham Offspring Study. Design and preliminary data. Prev Med 1975; 4: 518-525.
10. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP: An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979; 110: 281-290.
11. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
12. Clarke R, Daly LA Robinson K et al: Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-1155.
13. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ: Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995; 56: 142-150.
14. Kluijtmans LA, van den Heuvel LP, Boers GH et al: Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 35-41.
15. Tsai MY, Bignell M, Schwichtenberg K, Hanson NQ: High prevalence of a mutation in the cystathionine beta-synthase gene. Am J Hum Genet 1996; 59: 1262-1267.
16. Kluijtmans LA, Boers GH, Trijbels FJ, van Lith-Zanders HM, van den Heuvel LP, Blom HJ: A common 844INS68 insertion variant in the cystathionine beta-synthase gene. Biochem Mol Med 1997; 62: 23-25.
17. Tsai MY, Yang F, Bignell M, Aras O, Hanson NQ: Relation between plasma homocysteine concentration, the 844ins68 variant of the cystathionine beta-synthase gene, and pyridoxal-5′-phosphate concentration. Mol Genet Metab 1999; 67: 352-356.
18. Tsai MY, Bignell M, Yang F et al: Polygenic influence on plasma homocysteine: Association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels. Atherosclerosis 2000; 149: 131-137.
19. Kraus JP, Oliveriusova J, Sokolova J et al: The human cystathionine beta-synthase (CBS) gene: Complete sequence, alternative splicing, and polymorphisms. Genomics 1998; 52: 312-324.
20. Graham IM, Daly LE, Refsum HM et al: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277: 1775-1781.